 Evolent Health, Inc. NYSE: EVH, a health care company that delivers proven clinical and administrative solutions to payers and providers Evolent, announced today that it has entered into privately negotiated exchange andor subscription agreements, with certain holders of its outstanding 2.00 Convertible Senior Notes due 2021 the 2021 Notes and certain new investors pursuant to which Evolent will issue 84.2 million aggregate principal amount of 3.50 Convertible Senior Notes due 2024 the New Notes in exchange for 84.2 million aggregate principal amount of the 2021 Notes and an aggregate cash payment of 2.5 million the Exchange Transactions and issue 32.8 million aggregate principal amount of New Notes for cash at par the Subscription Transactions. The Exchange Transactions and the Subscription Transactions are expected to close concurrently on or about August 19, 2020, subject to customary closing conditions. 